22 min listen
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
ratings:
Length:
46 minutes
Released:
Oct 11, 2023
Format:
Podcast episode
Description
Dr Matthew Matasar from the Rutgers Cancer Institute of New Jersey in New York, New York, discusses the current and future role of CD20 x CD3 bispecific antibodies in the management of non-Hodgkin lymphoma.
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificNHL23)
CME information and select publications here (https://www.researchtopractice.com/OncologyTodayBispecificNHL23)
Released:
Oct 11, 2023
Format:
Podcast episode
Titles in the series (100)
Dr Tom Lynch on Adjuvant EGFR TKIs in Lung Cancer and COVID-19 in Seattle: Dr Tom Lynch comments on the current status of oncology research and data soon to be presented from a Phase III trial evaluating the EGFR TKI osimertinib as adjuvant therapy for patients with non-small cell lung cancer and EGFR tumor mutations. by Oncology Today with Dr Neil Love